Return on Assets: An indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Calculated as: Income from Continuing Operations / Total Assets
Virpax Pharmaceuticals, Inc. (VRPX) had Return on Assets of -775.72% for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-12.07M |
|
-- |
|
-- |
|
$12.08M |
|
$-12.08M |
|
$0.01M |
|
$-12.07M |
|
$-12.07M |
|
$-12.07M |
|
$-12.07M |
|
$-12.07M |
|
$-12.07M |
|
$-12.08M |
|
$-12.08M |
|
0.17M |
|
0.17M |
|
$-71.00 |
|
$-71.00 |
|
| Balance Sheet Financials | |
$1.56M |
|
-- |
|
-- |
|
$1.56M |
|
$2.47M |
|
-- |
|
-- |
|
$2.47M |
|
$-0.91M |
|
$-0.91M |
|
$-0.91M |
|
0.60M |
|
| Cash Flow Statement Financials | |
$-16.71M |
|
-- |
|
$9.08M |
|
$9.14M |
|
$1.51M |
|
$-7.63M |
|
$0.13M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.63 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-16.71M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
1320.62% |
|
1320.61% |
|
|
Return on Assets |
-775.72% |
1320.61% |
|
$-1.53 |
|
$-98.21 |
|
$-98.21 |
|